---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-280167"
form_type: "8-K"
ticker: "SERA"
cik: "0001534969"
company_name: "SERA PROGNOSTICS, INC."
filed_at: "2025-11-13T23:59:59+00:00"
generated_at: "2026-05-16T20:20:47.367076+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Sera Q3 revenue $16k, net loss $7.8M; launches Medicaid pilot in Nevada

## Summary
- Revenue $16k vs $29k YoY; net loss $7.8M vs $7.9M; cash $102.4M funds operations through 2028.
- Inaugural Medicaid pilot launched in Nevada; payer discussions across 13 states covering 33% of U.S. births.
- PRIME study full results on track for publication in 2025; health economic data also forthcoming.
- Appointed Dr. Tiffany Inglis as CMO and Marisol Urbano as Head of Commercial Operations.
- SG&A rose to $5.7M from $5.4M due to commercial investments; R&D fell to $3.3M as PRIME study concluded.

## SEC filing metadata
- accession: 0001193125-25-280167
- form_type: 8-K
- ticker: SERA
- cik: 0001534969
- company_name: SERA PROGNOSTICS, INC.
- filed_at: 2025-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534969/000119312525280167/0001193125-25-280167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534969/000119312525280167/sera-20251113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-280167
- JSON: https://secwatch.observer/filing/0001193125-25-280167.json
- Plain text: https://secwatch.observer/filing/0001193125-25-280167.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.